Our top pick for
Isoray, Inc is a medical instruments & supplies business based in the US. Isoray shares (ISR) are listed on the NYSE MKT and all prices are listed in US Dollars. Isoray employs 53 staff and has a trailing 12-month revenue of around USD$9.7 million.
|Latest market close||USD$0.42|
|52-week range||USD$0.35 - USD$1.03|
|50-day moving average||USD$0.4103|
|200-day moving average||USD$0.5587|
|Wall St. target price||USD$1.28|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.077|
|1 week (2021-01-07)||-68.89%|
|1 month (2020-12-17)||-12.50%|
|3 months (2020-10-15)||-26.32%|
|6 months (2020-07-15)||-33.33%|
|1 year (2020-01-15)||-47.50%|
|2 years (2019-01-15)||10.53%|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-15)||0.62|
|Revenue TTM||USD$9.7 million|
|Gross profit TTM||USD$5.1 million|
|Return on assets TTM||-23.1%|
|Return on equity TTM||-55.49%|
|Market capitalisation||USD$41 million|
TTM: trailing 12 months
There are currently 632,520 Isoray shares held short by investors – that's known as Isoray's "short interest". This figure is 23.9% down from 830,863 last month.
There are a few different ways that this level of interest in shorting Isoray shares can be evaluated.
Isoray's "short interest ratio" (SIR) is the quantity of Isoray shares currently shorted divided by the average quantity of Isoray shares traded daily (recently around 1.4 million). Isoray's SIR currently stands at 0.46. In other words for every 100,000 Isoray shares traded daily on the market, roughly 460 shares are currently held short.
However Isoray's short interest can also be evaluated against the total number of Isoray shares, or, against the total number of tradable Isoray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Isoray's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Isoray shares in existence, roughly 10 shares are currently held short) or 0.0073% of the tradable shares (for every 100,000 tradable Isoray shares, roughly 7 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Isoray.
Find out more about how you can short Isoray stock.
We're not expecting Isoray to pay a dividend over the next 12 months.
Isoray's shares were split on a 1:30 basis on 17 August 2005. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Isoray shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Isoray shares which in turn could have impacted Isoray's share price.
Over the last 12 months, Isoray's shares have ranged in value from as little as $0.35 up to $1.03. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Isoray's is 1.8619. This would suggest that Isoray's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.